Skip to main content
OpenTrials
Completed

NCT Number: NCT05495841

OPTiMASK: Comparison of Pre-oxygenation With Standard Face Mask Combined With High Flow Nasal Oxygen With Pre-oxygenation With Standard Face Mask Alone

This is an observational, prospective study of patients undergoing a surgical procedure. Three parallel studies are taking place with collaborators in other countries. This study aims to bring novel insights regarding the benefits of pre-oxygenation combining standard oxygen facemask with high-flow nasal oxygen (HFNO), as opposed to standard oxygen facemask alone by assessing end-tidal oxygen (ETO2) levels after intubation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

About this study

This is an observational, prospective study of patients undergoing a surgical procedure. A total of 80 patients will be enrolled at BIDMC. Patients meeting inclusion criteria with no exclusions will be approached for consent. 40 patients receiving the pre-oxygenation face mask alone method during clinical routine and 40 patients using the pre-oxygenation combined facemask + HFNO technique as part of routine clinical care will be studied. No randomization will be employed. Choice of pre-oxygenation approach is at the discretion of the clinician. Patients will be enrolled as a convenience sample, such that the first 40 patients will be those with face mask alone, and the second 40 will be patients with face mask + HFNO. Research assistants will discuss the pre-oxygenation plan with the anesthesiologist as part of the screening process. Data will be collected including EtO2 levels during two minutes following intubation.

Methodology

  • Face mask alone: As per clinical standard, the standard oxygen facemask will be tightly applied on the face of the patient at 100% FiO2 for 3 to 4 minutes. In case of suspected full stomach, it is recommended to perform a rapid sequence induction and the patient does not receive bag-mask ventilation during the apnea period (45-60s). In the other case, a standard pre-oxygenation will be performed (see figure 1: experimental design of the study).
  • Face mask + Nasal cannula: As to clinical standards, the standard oxygen facemask will be tightly applied on the face of the patient at 100% FiO2 for 3 to 4 minutes and HFNO at 100% with a flow at 40 L/minutes during the pre-oxygenation (the flow can be decreased to less than 40 L/minutes if no tolerance by the patient). Then, after a general anesthesia induction and/or a rapid sequence induction is performed, the patient receives HFNO at 100% FiO2 and the flow of HFNO is increased to up to 80 L/minutes (which corresponds to a close delivered FiO2 at 80%) during the apnea period (1 to 2 min) until correct position of the endotracheal tube is confirmed with capnography.

Assessments The study does not require any research procedures other than passive data collection. For this study, EtO2 levels will be recorded at more frequent intervals than what is entered in the anesthesia record. Therefore, study staff will collect these data from the anesthesia machine in the operating room, where values are displayed on a breath-by-breath basis

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years and older
  • All consecutive patients for scheduled or non-scheduled surgery with or without indication of rapid sequence induction (full-stomach)
  • Undergoing general anesthesia with orotracheal intubation

Exclusion criteria

  • Age < 18 years
  • Hemodynamic instability
  • Intubation without laryngoscopy (i.e., fiberoptic intubation for anticipated "cannot ventilate situation" or mouth opening < 2 cm), facial surgery
  • Adults subject to legal protection
  • Pregnancy (due to higher risk of oxygen desaturation and aspiration)

Treatment and study plan

Pre-oxygenation

Device

Process of administrating oxygen prior to intubation

Primary outcomes

  1. Lowest EtO2 value

    Time frame: start of intubation to 2 minutes after

    Lowest EtO2 value within the two minutes following tracheal intubation

Secondary outcomes

  1. SpO2 at the start and at the end of the procedure

    Time frame: start of intubation to 4 minutes after

    SpO2 at the start and at the end of the procedure and EtO2 each minute during the four minutes of pre-oxygenation

  2. Tolerance of the device

    Time frame: entirety of procedure

    Tolerance of the device (discomfort considered if the patient asks for reduction of the gas flow of HFNC: Yes or No

  3. Lowest SpO2

    Time frame: start of intubation to 2 minutes after

    Lowest SpO2 during intubation and within 2 min after intubation

  4. Highest level of EtCO2

    Time frame: start of intubation to 2 minutes after

    Highest level of EtCO2 within 2 min following intubation

  5. Rate of oxygen desaturation

    Time frame: entirety of procedure

    Rate of oxygen desaturation below 95% during the procedure

  6. Number of laryngoscopy attempts

    Time frame: before surgical procedure

    Number of laryngoscopy attempts before successful tracheal intubation

Sponsors and collaborators

Lead sponsor

Beth Israel Deaconess Medical Center

Other

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Aug 10, 2022
Registry last updated
Nov 30, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.